siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma cells

被引:24
|
作者
Furukawa, Kaori [1 ]
Tanaka, Masakazu [1 ]
Oba, Makoto [1 ]
机构
[1] Nagasaki Univ, Grad Sch Biomed Sci, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan
关键词
Cell-penetrating peptide; siRNA delivery; Peptide foldamer; alpha; alpha-Disubstituted alpha-amino acid; Helical structure; ALPHA-AMINO-ACIDS; HELICAL PEPTIDES; NUCLEIC-ACIDS; AIB; DESIGN; VECTORS; RNA;
D O I
10.1016/j.bmc.2020.115402
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cell-penetrating peptides (CPPs) are an attractive tool for delivering membrane-impermeable compounds, including anionic biomacromolecules such as DNA and RNA, into living cells. Amphipathic helical peptides composed of hydrophobic amino acids and cationic amino acids are typical CPPs. In the current study, we designed amphipathic helical 12-mer peptides containing alpha,alpha-disubstituted alpha-amino acids (dAAs), which are known to stabilize peptide secondary structures. The dominant secondary structures of peptides in aqueous solution differed according to the introduced dAAs. Peptides containing hydrophobic dAAs and adopting a helical structure exhibited a good cell-penetrating ability. As an application of amphipathic helical peptides, small interfering RNA (siRNA) delivery into living human hepatoma cells was investigated. One of the peptides containing dAAs dipropylglycine formed stable complexes with siRNA at appropriate zeta-potential and size for intracellular siRNA delivery. This peptide showed effective RNA interference efficiency at short peptide length and low concentrations of peptide and siRNA. These findings will be helpful for the design of amphipathic helical CPPs as intracellular siRNA delivery.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Intracellular Delivery of Plasmid DNA Using Amphipathic Helical Cell-Penetrating Peptides Containing Dipropylglycine
    Naka, Motoki
    Umeno, Tomohiro
    Shibuya, Mika
    Yamaberi, Yuto
    Ueda, Atsushi
    Tanaka, Masakazu
    Takemoto, Hiroyasu
    Oba, Makoto
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2024, 72 (05) : 512 - 517
  • [2] Cell-penetrating peptides for siRNA delivery to glioblastomas
    Srimanee, Artita
    Arvanitidou, Maria
    Kim, Kumjee
    Hallbrink, Mattias
    Langel, Ulo
    PEPTIDES, 2018, 104 : 62 - 69
  • [3] Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape
    Endoh, Tamaki
    Ohtsuki, Takashi
    ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (09) : 704 - 709
  • [4] Versatility of cell-penetrating peptides for intracellular delivery of siRNA
    Singh, Tejinder
    Murthy, Akula S. N.
    Yang, Hye-Jin
    Im, Jungkyun
    DRUG DELIVERY, 2018, 25 (01) : 1996 - 2006
  • [5] Intracellular delivery of siRNA by cell-penetrating peptides modified with cationic oligopeptides
    Ishihara, Tsutomu
    Goto, Maoko
    Kodera, Kanae
    Kanazawa, Hideko
    Murakami, Yasuko
    Mizushima, Yutaka
    Higaki, Megumu
    DRUG DELIVERY, 2009, 16 (03) : 153 - 159
  • [6] Comparison of Cationic and Amphipathic Cell Penetrating Peptides for siRNA Delivery and Efficacy
    Mo, Robert H.
    Zaro, Jennica L.
    Shen, Wei-Chiang
    MOLECULAR PHARMACEUTICS, 2012, 9 (02) : 299 - 309
  • [7] Intelligent substance delivery into cells using cell-penetrating peptides
    Tashima, Toshihiko
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (02) : 121 - 130
  • [8] Insight into the Cellular Uptake Mechanism of a Secondary Amphipathic Cell-Penetrating Peptide for siRNA Delivery
    Konate, Karidia
    Crombez, Laurence
    Deshayes, Sebastien
    Decaffmeyer, Marc
    Thomas, Annick
    Brasseur, Robert
    Aldrian, Gudrun
    Heitz, Frederic
    Divita, Gilles
    BIOCHEMISTRY, 2010, 49 (16) : 3393 - 3402
  • [9] Therapeutic delivery using cell-penetrating peptides
    Sawant, Rupa R.
    Patel, Niravkumar R.
    Torchilin, Vladimir P.
    EUROPEAN JOURNAL OF NANOMEDICINE, 2013, 5 (03) : 141 - 158
  • [10] Is there a future for cell-penetrating peptides in oligonucleotide delivery?
    Lee, Soo Hyeon
    Castagner, Bastien
    Leroux, Jean-Christophe
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2013, 85 (01) : 5 - 11